Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Are circulating tumor cells an independent prognostic factor in patients with high-risk melanoma?

Nature Clinical Practice Oncology volume 1, pages 74–75 (2004)Cite this article

boxed-textMocellin S et al. (2004) Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma. Int J Cancer 111: 741–745

Background

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Smith B et al. (1991) Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227–1229

    Article  CAS  Google Scholar 

  2. Hoon DS et al. (2000) Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res 60: 2253–2257

    CAS  PubMed  Google Scholar 

  3. Wascher RA et al. (2003) Molecular tumor markers in the blood: Early prediction of disease outcome in melanoma patients treated with a melanoma vaccine. J Clin Oncol 21: 2558–2563

    Article  CAS  Google Scholar 

  4. Keilholz U et al. (2004) Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction. Clin Cancer Res 10: 1605–1612

    Article  CAS  Google Scholar 

  5. Taback B et al. (2004) Circulating DNA microsatellites: Molecular determinants of response to biochemotherapy in patients with metastatic melanoma. J Natl Cancer Inst 96: 152–156

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Director of the Department of Molecular Oncology, John Wayne Cancer Institute,

    Dave SB Hoon

Authors
  1. Dave SB Hoon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dave SB Hoon.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoon, D. Are circulating tumor cells an independent prognostic factor in patients with high-risk melanoma?. Nat Rev Clin Oncol 1, 74–75 (2004). https://doi.org/10.1038/ncponc0041

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0041

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing